Igf-1 and related compounds in pregnancy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/30 (2006.01)

Patent

CA 2087030

2087030 9200754 PCTABS00010 Fetal growth is promoted, and fetal growth retardation is reduced, in mammals by increasing in a maternal host during pregnancy the active concentration of IGF-1 and/or IGF-2 and/or analogues thereof. The active concentration of IGF-1 and/or IGF-2 and/or analogues thereof may be increased by administering such a compound to the maternal host, or by administering to the maternal host a compound, such as placental lactogen, which upon being so administered increases the active concentration of IGF-1 and/or IGF-2 and/or analogues thereof in the maternal host.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Igf-1 and related compounds in pregnancy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Igf-1 and related compounds in pregnancy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Igf-1 and related compounds in pregnancy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1620582

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.